INOVIO PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Inovio Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Inovio Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 26.1M shares, a 90.4% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 26.1M -247M -90.4% Nov 12, 2024 10-Q 2024-11-14
Q2 2024 26M -242M -90.3% Aug 8, 2024 10-Q 2024-08-08
Q1 2024 23.4M -237M -91% Mar 1, 2024 10-K 2024-03-06
Q3 2023 273M +23.5M +9.42% Nov 8, 2023 10-Q 2023-11-09
Q2 2023 268M +18.7M +7.49% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 260M +42.7M +19.7% Feb 24, 2023 10-K 2023-03-01
Q3 2022 249M +39.1M +18.6% Nov 7, 2022 10-Q 2022-11-08
Q2 2022 249M +39M +18.6% Aug 5, 2022 10-Q 2022-08-09
Q1 2022 217M +9.77M +4.71% Feb 25, 2022 10-K 2022-03-01
Q3 2021 210M +41M +24.2% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 210M +42.8M +25.6% Aug 6, 2021 10-Q 2021-08-09
Q1 2021 208M +61.8M +42.4% Feb 26, 2021 10-K 2021-03-01
Q3 2020 169M +69.4M +69.4% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 168M +68.5M +69.2% Aug 7, 2020 10-Q 2020-08-10
Q1 2020 146M +48.2M +49.3% Mar 11, 2020 10-K 2020-03-12
Q3 2019 100M +4.66M +4.89% Nov 7, 2019 10-Q 2019-11-12
Q2 2019 99M +7.53M +8.23% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 97.6M +7.23M +8% Mar 8, 2019 10-K 2019-03-12
Q3 2018 95.3M +5.05M +5.59% Nov 2, 2018 10-Q 2018-11-08
Q2 2018 91.5M +1.27M +1.41% Aug 3, 2018 10-Q 2018-08-07
Q1 2018 90.4M +16.3M +22% Mar 8, 2018 10-K 2018-03-14
Q3 2017 90.3M +16.2M +21.9% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 90.2M +16.7M +22.7% Aug 4, 2017 10-Q 2017-08-08
Q1 2017 74.1M +1.88M +2.6% Mar 8, 2017 10-K 2017-03-15
Q3 2016 74.1M +1.88M +2.6% Nov 1, 2016 10-Q 2016-11-09
Q2 2016 73.5M +1.43M +1.99% Aug 1, 2016 10-Q 2016-08-08
Q1 2016 72.2M +11.5M +18.9% Mar 7, 2016 10-K 2016-03-14
Q3 2015 72.2M +11.6M +19.1% Nov 2, 2015 10-Q 2015-11-09
Q2 2015 72.1M +11.7M +19.4% Aug 3, 2015 10-Q 2015-08-10
Q1 2015 60.7M -179M -74.7% Mar 9, 2015 10-K 2015-03-16
Q3 2014 60.6M -148M -70.9% Nov 3, 2014 10-Q 2014-11-10
Q2 2014 60.4M -130M -68.2% Aug 4, 2014 10-Q 2014-08-11
Q1 2014 240M +59.7M +33.2% Mar 7, 2014 10-K 2014-03-17
Q3 2013 208M +69M +49.5% Nov 4, 2013 10-Q 2013-11-12
Q2 2013 190M +54.9M +40.7% Aug 8, 2013 10-Q 2013-08-09
Q1 2013 180M +45M +33.3% Mar 8, 2013 10-K 2013-03-18
Q3 2012 139M +12.1M +9.5% Nov 2, 2012 10-Q 2012-11-07
Q2 2012 135M +7.71M +6.06% Aug 2, 2012 10-Q 2012-08-09
Q1 2012 135M May 4, 2012 10-Q 2012-05-09
Q3 2011 127M Oct 26, 2011 10-Q 2011-11-07
Q2 2011 127M Jul 27, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.